[EN] Benzimidazole derivatives and their use as cannabinoid receptor ligands<br/>[FR] DERIVES DE BENZIMIDAZOLE ET LEUR UTILISATION EN TANT QUE LIGANDS DU RECEPTEUR CANNABINOIDE
申请人:ASTRAZENECA AB
公开号:WO2006033629A1
公开(公告)日:2006-03-30
Compounds of Formula I, or pharmaceutically acceptable salts thereof: (I) wherein R1, R2, R3, R4, and R5 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
式I的化合物,或其药用可接受的盐:(I)其中R1、R2、R3、R4和R5如规范中定义的那样,以及包括这些化合物的盐和药物组合物已经制备。它们在治疗中很有用,特别是在疼痛管理中。